As part of this expansion, ten23 health appoints Noriko Utsumi as Business Development Director for Japan and the broader Asia-Pacific region. Noriko brings extensive experience in the life sciences industry and a strong track record of building client relationships and driving growth in the region.

“We are excited to establish a presence in Japan, one of the world’s leading countries for pharmaceuticals and biotechnology innovation,” said Hanns-Christian Mahler, Chief Enablement Officer.

In her role, Noriko Utsumi will be responsible for expanding ten23 commercial activities in the region, working closely with clients to support their drug development and manufacturing needs. Her deep understanding of the local market and customer requirements will be instrumental in accelerating the company’s growth in Asia. 
“I am thrilled to join ten23 health at such an exciting time,” said Noriko Utsumi. “The company’s commitment to quality, innovation, and client-centric solutions, and the alignment of Swiss and Japanese quality, makes it uniquely positioned to support the growing needs of the Asian market. I look forward to contributing to its expansion and building long-term partnerships in the region.”

The Japan office represents ten23 health’s first physical presence in Asia and underscores its ambition to become a truly global partner for pharmaceutical and biotech companies.